Long-term ABT199 treatment of non-Hodgkin lymphoma cells resulted in upregulated levels of anti-apoptotic proteins MCL-1 and BCL-XL that sequestered BIM [29]. The gene discussed is BCL2L1; the disease is non-Hodgkin lymphoma.